{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T19:19:51Z","timestamp":1789154391966,"version":"build-2803163510"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,3,3]]},"DOI":"10.7759\/cureus.79945","type":"journal-article","created":{"date-parts":[[2025,3,3]],"date-time":"2025-03-03T08:56:07Z","timestamp":1740992167000},"source":"Crossref","is-referenced-by-count":1,"title":["A Case of Pediatric Myasthenia Revealed by Marked Eyelid Ptosis After Using Cyclopentolate Eye Drops"],"prefix":"10.7759","author":[{"given":"Kaori","family":"Komatsu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoko","family":"Yoshikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiaki","family":"Kiuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1111\/ane.12193","article-title":"Muscle strength in myasthenia gravis","volume":"129","author":"Cejvanovic S","year":"2014","unstructured":"Cejvanovic S, Vissing J. Muscle strength in myasthenia gravis. Acta Neurol Scand. 2014, 129:367-73. 10.1111\/ane.12193","journal-title":"Acta Neurol Scand"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3233\/JND-170294","article-title":"New pathways and therapeutic targets in autoimmune myasthenia gravis","volume":"5","author":"Behin A","year":"2018","unstructured":"Behin A, Le Panse R. New pathways and therapeutic targets in autoimmune myasthenia gravis. J Neuromuscul Dis. 2018, 5:265-77. 10.3233\/JND-170294","journal-title":"J Neuromuscul Dis"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1055\/s-0033-1364181","article-title":"Juvenile myasthenia gravis: recommendations for diagnostic approaches and treatment","volume":"45","author":"Della Marina A","year":"2014","unstructured":"Della Marina A, Trippe H, Lutz S, Schara U. Juvenile myasthenia gravis: recommendations for diagnostic approaches and treatment. Neuropediatrics. 2014, 45:75-83. 10.1055\/s-0033-1364181","journal-title":"Neuropediatrics"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1602678","article-title":"Myasthenia gravis","volume":"375","author":"Gilhus NE","year":"2016","unstructured":"Gilhus NE. Myasthenia gravis. N Engl J Med. 2016, 375:2570-81. 10.1056\/NEJMra1602678","journal-title":"N Engl J Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.4061\/2011\/404101","article-title":"Juvenile myasthenia gravis: a paediatric perspective","volume":"2011","author":"Finnis MF","year":"2011","unstructured":"Finnis MF, Jayawant S. Juvenile myasthenia gravis: a paediatric perspective. Autoimmune Dis. 2011, 2011:404101. 10.4061\/2011\/404101","journal-title":"Autoimmune Dis"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1007\/s10072-013-1443-4","article-title":"The effect of steroid treatment and thymectomy on bone age and height development in juvenile myasthenia gravis","volume":"34","author":"Wang H","year":"2013","unstructured":"Wang H, Su Z, Luo C, et al.. The effect of steroid treatment and thymectomy on bone age and height development in juvenile myasthenia gravis. Neurol Sci. 2013, 34:2173-80. 10.1007\/s10072-013-1443-4","journal-title":"Neurol Sci"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1080\/08164622.2022.2029683","article-title":"Ocular myasthenia gravis: a review and practical guide for clinicians","volume":"105","author":"Shuey NH","year":"2022","unstructured":"Shuey NH. Ocular myasthenia gravis: a review and practical guide for clinicians. Clin Exp Optom. 2022, 105:205-13. 10.1080\/08164622.2022.2029683","journal-title":"Clin Exp Optom"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/874680","article-title":"Myasthenia gravis: a review","volume":"2012","author":"Jayam Trouth A","year":"2012","unstructured":"Jayam Trouth A, Dabi A, Solieman N, Kurukumbi M, Kalyanam J. Myasthenia gravis: a review. Autoimmune Dis. 2012, 2012:874680. 10.1155\/2012\/874680","journal-title":"Autoimmune Dis"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.spen.2017.04.003","article-title":"Pediatric myasthenia gravis","volume":"24","author":"Peragallo JH","year":"2017","unstructured":"Peragallo JH. Pediatric myasthenia gravis. Semin Pediatr Neurol. 2017, 24:116-21. 10.1016\/j.spen.2017.04.003","journal-title":"Semin Pediatr Neurol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.48.12.1246","article-title":"Acetylcholine receptor antibody as a diagnostic test for myasthenia gravis: results in 153 validated cases and 2967 diagnostic assays","volume":"48","author":"Vincent A","year":"1985","unstructured":"Vincent A, Newsom-Davis J. Acetylcholine receptor antibody as a diagnostic test for myasthenia gravis: results in 153 validated cases and 2967 diagnostic assays. J Neurol Neurosurg Psychiatry. 1985, 48:1246-52. 10.1136\/jnnp.48.12.1246","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref11","article-title":"Neurophysiological parameters in myasthena gravis in children in diagnostic and therapeutic view [Article in Polish]","volume":"73","author":"Kroczka S","year":"2016","unstructured":"Kroczka S, Stasiak K, Kacinski M. Neurophysiological parameters in myasthena gravis in children in diagnostic and therapeutic view [Article in Polish]. Przegl Lek. 2016, 73:119-23.","journal-title":"Przegl Lek"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1007\/s00266-003-0127-5","article-title":"Ptosis: causes, presentation, and management","volume":"27","author":"Finsterer J","year":"2003","unstructured":"Finsterer J. Ptosis: causes, presentation, and management. Aesthetic Plast Surg. 2003, 27:193-204. 10.1007\/s00266-003-0127-5","journal-title":"Aesthetic Plast Surg"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2011-3084","article-title":"Patient- and family-centered care and the pediatrician's role","volume":"129","year":"2012","unstructured":"Patient- and family-centered care and the pediatrician's role. Pediatrics. 2012, 129.394-404. 10.1542\/peds.2011-3084","journal-title":"Pediatrics"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1177\/1043454209349358","article-title":"How children with cancer communicate and think about symptoms","volume":"27","author":"Vatne TM","year":"2010","unstructured":"Vatne TM, Slaugther L, Ruland CM. How children with cancer communicate and think about symptoms. J Pediatr Oncol Nurs. 2010, 27:24-32. 10.1177\/1043454209349358","journal-title":"J Pediatr Oncol Nurs"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3390\/bs11090116","article-title":"Using appreciative inquiry to explore effective medical interviews","volume":"11","author":"Khawaja M","year":"2021","unstructured":"Khawaja M. Using appreciative inquiry to explore effective medical interviews. Behav Sci (Basel). 2021, 11:10.3390\/bs11090116","journal-title":"Behav Sci (Basel)"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/343165-a-case-of-pediatric-myasthenia-revealed-by-marked-eyelid-ptosis-after-using-cyclopentolate-eye-drops","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,3]],"date-time":"2025-03-03T08:56:09Z","timestamp":1740992169000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/343165-a-case-of-pediatric-myasthenia-revealed-by-marked-eyelid-ptosis-after-using-cyclopentolate-eye-drops"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,3]]},"references-count":15,"URL":"https:\/\/doi.org\/10.7759\/cureus.79945","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3,3]]}}}